What is Sarepta Therapeutics, Inc.'s net income?

Sarepta Therapeutics, Inc. (SRPT) reported net income of $330.96M in Q1 2026.

How has Sarepta Therapeutics, Inc.'s net income changed year-over-year?

Sarepta Therapeutics, Inc.'s net income increased by 174.0% year-over-year, from -$447.51M to $330.96M.

What is the long-term trend for Sarepta Therapeutics, Inc.'s net income?

Over 3 years (2021 to 2024), Sarepta Therapeutics, Inc.'s net income has grown at a -17.5% compound annual growth rate (CAGR), from -$418.78M to $235.24M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Sarepta Therapeutics, Inc. SRPT Net Income

Net Income at other companies

PfizerPFE

$2.7B-9.3%

Regeneron PharmaceuticalsREGN

$727.2M-10.1%

BioMarin PharmaceuticalsBMRN

$105.53M-43.2%

PTC TherapeuticsPTCT

-$2.81M-100%

InsmedINSM

-$163.56M+36.3%

Capricor TherapeuticsCAPR

-$33.94M-39.2%

Segments

By segment

See full

All Other Segments$330.96M+174%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.76B-63.1%

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s net income?: Sarepta Therapeutics, Inc. (SRPT) reported net income of $330.96M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s net income changed year-over-year?: Sarepta Therapeutics, Inc.'s net income increased by 174.0% year-over-year, from -$447.51M to $330.96M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s net income?: Over 3 years (2021 to 2024), Sarepta Therapeutics, Inc.'s net income has grown at a -17.5% compound annual growth rate (CAGR), from -$418.78M to $235.24M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.